StockWatch
·
Pharmaceuticals
Merger14 Nov 2026, 12:02 pm

Rubicon Research Merger Application Returned by MCA

AI Summary

Rubicon Research Ltd has announced that its application for the fast-track approval of the merger scheme with KIA Health Tech Pvt Ltd has been returned by the Regional Director, Western Region, Ministry of Corporate Affairs. The application was rejected due to unmet conditions, specifically the shareholder approval percentage (88.65% vs. 90% required) and unsecured creditor approval percentage (71.83% vs. 90% required). The company is now evaluating options, including pursuing the merger through the regular NCLT process. Rubicon Research stated that this development does not materially impact its business operations, as KIA Health Tech Pvt Ltd currently has no operations.

Key Highlights

  • Merger application with KIA Health Tech returned by MCA.
  • Shareholder and creditor approval thresholds not met for fast-track approval.
  • Company evaluating NCLT regular process as an alternative.
  • No material impact on business operations expected.